Form 4: Intuitive Surgical Executive Robert DeSantis Executes Stock Options and Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, exercised stock options and sold shares of ISRG common stock under a pre-arranged 10b5-1 trading plan.
Summary
- Robert DeSantis, an executive at Intuitive Surgical Inc. (ISRG), engaged in transactions involving the company's common stock on November 11, 2024.
- DeSantis exercised non-qualified stock options to acquire 119 shares at $229.39 and 120 shares at $304.67.
- Simultaneously, DeSantis sold 119 shares at $539.89 and 120 shares at $539.89.
- These transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
- Following these transactions, DeSantis directly owns 5,506 shares of Intuitive Surgical common stock.
- DeSantis also holds options to purchase 3,233 shares at $229.39 expiring on February 27, 2030, and 3,232 shares at $304.67 expiring on August 9, 2030.
Sentiment
Score: 5
Explanation: The document reflects routine executive stock transactions under a pre-arranged plan, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. These transactions are often scrutinized by investors to gauge management's confidence in the company's future prospects. The use of a 10b5-1 trading plan allows insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across the medical device industry.
- Companies like Stryker (SYK) and Medtronic (MDT) also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices of these options are generally aligned with industry benchmarks to incentivize long-term performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership of shares.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/10/2023 | Date from which 12.5% of the shares subject to the $229.39 option vest on the six-month anniversary. |
| 08/10/2023 | Date from which 7/48th of the shares subject to the $304.67 option vest on the one-month anniversary. |
| 02/27/2030 | Expiration date of non-qualified stock options to buy 3,233 shares at $229.39. |
| 08/09/2030 | Expiration date of non-qualified stock options to buy 3,232 shares at $304.67. |
| 11/11/2024 | Date of stock option exercise and sale of shares. |
| 12/09/2024 | Expiration date of the 10b5-1 trading plan. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.